PDE5 inhibitors in treatment of erectile dysfunction and cardiovascular safety

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Erectile dysfunction (ED) is a disease marker for cardiovascular disease. Men with ED should be properly assessed and investigated before starting treatment. The PDE5 inhibitors, including sildenafil, proved to be safe and effective treatment for this disorder.

Full Text

Restricted Access

About the authors

Igor Alexeyevich Korneyev

First State Pavlov Medical University of St Petersburg

Email: iakorneyev@yandex.ru
doctor of medical science, professor. Department of Urology

References

  1. Dong J. Y., Zhang Y. H., Qin L. Q. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies // J Am Coll Cardiol. 2011. Vol. 58, N 13. P. 1378-1385.
  2. Gazzaruso C., Coppola A., Montalcini T. et al. Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes // Endocrine. 2011. Vol. 40, N 2. P. 273-279.
  3. Nehra A., Jackson G., Miner M. et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease // Mayo Clin Proc. 2012. Vol. 87, N 8. P.766-778.
  4. Cheitlin M. D. Sexual activity and cardiac risk // Am J Cardiol. 2005. Vol. 96. 24M-28M.
  5. Kostis J., Jackson G., Rosen R. et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference) // Am J Cardiol. 2005. Vol. 96, N 2. P. 313-321.
  6. Guay A. T. Optimizing response to phosphodiesterase therapy: impact of risk-factor management // J Androl. 2003. Vol. 24, N 6 (Suppl). S59-S62.
  7. Moyad M. A., Barada J. H., Lue T. F. et al. Sexual Medicine Society Nutraceutical Committee. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I // Urol Clin North Am. 2004. Vol. 31, N 2. P.249-257.
  8. Moyad M. A., Barada J. H., Lue T. F. et al. Sexual Medicine Society Nutraceutical Committee. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II // Urol Clin North Am. 2004. Vol. 31, N 2. P.259-273.
  9. Greenstein A., Mabjeesh N. J., Sofer M. et al. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? // J Urol. 2005. Vol.173, N 2. P. 530-532.
  10. Cheitlin M. D., Hutter A. M. Jr, Brindis R. G. et al. Technology and Practice Executive Committee. Use of sildenafil (Viagra) in patients with cardiovascular disease [published correction appears in Circulation. 1999;100:2389] // Circulation. 1999. Vol. 99. P.168 -177.
  11. Padma-Nathan H., Eardley I., Kloner R. A. et al. A 4-year update on the safety of sidlenafil citrate (Viagra) // Urology. 2002. Vol. 60 (Suppl 2B). P. 67-90.
  12. Herrmann H. C., Chang G., Klugherz B. D. et al. Hemodynamic effects of sildenafil in men with severe coronary artery disease // N Engl J Med. 2000. Vol. 342, № 22. P.1622-1626.
  13. Carson C. C. III. Sildenafil: A 4-Year Update in the Treatment of 20 Million Erectile Dysfunction Patients // Current Urology Reports. 2003. Vol. 4. P. 488-496.
  14. Корнеев И. А. Длительное ингибирование фосфодиэстеразы 5 типа: эффекты, перспективы применения в урологической практике // Эффективная фармакотерапия. 16/2013. Урология и нефрология. № 2. С. 14-17.
  15. Мазо Е. Б., Гамидов С. И., Овчинников Р. И., Иремашвили В. В. Безопасность сексуальной активности у больных сердечно-сосудистыми заболеваниями // Фарматека. 2004. N 11. С. 8-12.

Statistics

Views

Abstract: 435

PDF (Russian): 200

Dimensions

Article Metrics

Metrics Loading ...

PlumX


Copyright (c) 2015 Korneyev I.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies